• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国机器人辅助妇科良性疾病子宫切除术:住院期间使用阿片类和非阿片类镇痛药。

Robotic-assisted hysterectomy for benign gynecologic disease in the United States: in-hospital use of opioid and non-opioid analgesics.

机构信息

Department of Obstetrics and Gynecology, Mayo Clinic, 200 First St SW, Rochester, MN, 55905, USA.

Unit of Gynecology and Obstetrics, Department of Surgery, Dentistry, Pediatrics, and Gynecology, AOUI Verona, University of Verona, Verona, Italy.

出版信息

J Robot Surg. 2024 Apr 26;18(1):182. doi: 10.1007/s11701-024-01948-0.

DOI:10.1007/s11701-024-01948-0
PMID:38668935
Abstract

To compare the in-hospital opioid and non-opioid analgesic use among women who underwent robotic-assisted hysterectomy (RH) vs. open (OH), vaginal (VH), or laparoscopic hysterectomy (LH). Records of women in the United States who underwent hysterectomy for benign gynecologic disease were extracted from the Premier Healthcare Database (2013-2019). Propensity score methods were used to create three 1:1 matched cohorts stratified in inpatients [RH vs. OH (N = 16,821 pairs), RH vs. VH (N = 6149), RH vs. LH (N = 11,250)] and outpatients [RH vs. OH (N = 3139), RH vs. VH (N = 29,954), RH vs. LH (N = 85,040)]. Opioid doses were converted to morphine milligram equivalents (MME). Within matched cohorts, opioid and non-opioid analgesic use was compared. On the day of surgery, the percentage of patients who received opioids differed only for outpatients who underwent RH vs. LH or VH (maximum difference = 1%; p < 0.001). RH was associated with lower total doses of opioids in all matched cohorts (each p < 0.001), with the largest difference observed between RH and OH: median (IQR) of 47.5 (25.0-90.0) vs. 82.5 (36.0-137.0) MME among inpatients and 39.3 (19.5-66.0) vs. 60.0 (35.0-113.3) among outpatients. After the day of surgery, fewer inpatients who underwent RH received opioids vs. OH (78.7 vs. 87.5%; p < 0.001) or LH (78.6 vs. 80.6%; p < 0.001). The median MME was lower for RH (15.0; 7.5-33.5) versus OH (22.5; 15.0-55.0; p < 0.001). Minor differences were observed for non-opioid analgesics. RH was associated with lower in-hospital opioid use than OH, whereas the same magnitude of difference was not observed for RH vs. LH or VH.

摘要

比较行机器人辅助子宫切除术(RH)与开腹(OH)、阴道(VH)或腹腔镜子宫切除术(LH)的女性住院期间阿片类药物和非阿片类药物的使用情况。从 Premier Healthcare Database(2013-2019 年)中提取了美国因良性妇科疾病接受子宫切除术的女性记录。使用倾向评分方法创建了三个 1:1 匹配队列,按住院患者分层[RH 与 OH(N=16821 对),RH 与 VH(N=6149),RH 与 LH(N=11250)]和门诊患者[RH 与 OH(N=3139),RH 与 VH(N=29954),RH 与 LH(N=85040)]。阿片类药物剂量换算为吗啡毫克当量(MME)。在匹配队列内,比较阿片类药物和非阿片类药物的使用情况。在手术当天,仅接受 RH 与 LH 或 VH 的门诊患者的接受阿片类药物的患者比例有所不同(最大差异为 1%;p<0.001)。在所有匹配队列中,RH 与较低的阿片类药物总剂量相关(均 p<0.001),其中 RH 与 OH 的差异最大:住院患者中位数(IQR)为 47.5(25.0-90.0)与 82.5(36.0-137.0)MME;门诊患者为 39.3(19.5-66.0)与 60.0(35.0-113.3)。手术日之后,接受 RH 的住院患者中接受阿片类药物的患者少于接受 OH(78.7% vs. 87.5%;p<0.001)或 LH(78.6% vs. 80.6%;p<0.001)。RH 患者的中位数 MME 低于 OH(15.0;7.5-33.5)(p<0.001)。非阿片类药物镇痛药的差异较小。RH 与较低的住院期间阿片类药物使用量相关,而 RH 与 LH 或 VH 之间没有观察到相同幅度的差异。

相似文献

1
Robotic-assisted hysterectomy for benign gynecologic disease in the United States: in-hospital use of opioid and non-opioid analgesics.美国机器人辅助妇科良性疾病子宫切除术:住院期间使用阿片类和非阿片类镇痛药。
J Robot Surg. 2024 Apr 26;18(1):182. doi: 10.1007/s11701-024-01948-0.
2
Surgical approach to hysterectomy for benign gynaecological disease.良性妇科疾病子宫切除术的手术入路
Cochrane Database Syst Rev. 2015 Aug 12;2015(8):CD003677. doi: 10.1002/14651858.CD003677.pub5.
3
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
4
Surgical approach to hysterectomy for benign gynaecological disease.良性妇科疾病的子宫切除术手术入路。
Cochrane Database Syst Rev. 2023 Aug 29;8(8):CD003677. doi: 10.1002/14651858.CD003677.pub6.
5
Comparative safety and effectiveness of robot-assisted laparoscopic hysterectomy versus conventional laparoscopy and laparotomy for endometrial cancer: A systematic review and meta-analysis.机器人辅助腹腔镜子宫切除术与传统腹腔镜手术及剖腹手术治疗子宫内膜癌的比较安全性和有效性:一项系统评价和荟萃分析。
Eur J Surg Oncol. 2016 Sep;42(9):1303-14. doi: 10.1016/j.ejso.2016.06.400. Epub 2016 Jun 29.
6
Oral analgesia for relieving post-caesarean pain.口服镇痛用于缓解剖宫产术后疼痛。
Cochrane Database Syst Rev. 2015 Mar 29;2015(3):CD010450. doi: 10.1002/14651858.CD010450.pub2.
7
Perioperative opioid dispensing and persistent use after benign hysterectomy: a systematic review and meta-analysis.良性子宫切除术后围手术期阿片类药物配给与持续使用:系统评价和荟萃分析。
Am J Obstet Gynecol. 2023 Jul;229(1):23-32.e3. doi: 10.1016/j.ajog.2022.12.015. Epub 2022 Dec 17.
8
Robot-assisted surgery in gynaecology.妇科机器人辅助手术
Cochrane Database Syst Rev. 2014 Dec 10;2014(12):CD011422. doi: 10.1002/14651858.CD011422.
9
Persistent opioid use among patients who underwent intermediate-to-major elective surgery at a Swiss cantonal hospital: a prospective cohort study.瑞士一家州立医院接受中大型择期手术患者的持续阿片类药物使用情况:一项前瞻性队列研究。
Swiss Med Wkly. 2025 May 15;155:4152. doi: 10.57187/s.4152.
10
The Beginning of a Paradigm Shift: Increase in Perioperative Complications Following Vaginal Hysterectomy Compared to Laparoscopic Hysterectomy Using the ACS-NSQIP 2016 to 2019 Database.范式转变的开端:利用2016年至2019年美国外科医师学会国家外科质量改进计划(ACS-NSQIP)数据库比较阴道子宫切除术后与腹腔镜子宫切除术后围手术期并发症的增加情况
J Minim Invasive Gynecol. 2025 Jul;32(7):629-638. doi: 10.1016/j.jmig.2025.01.016. Epub 2025 Feb 4.

本文引用的文献

1
Prescription Opioid Use for Acute Pain and Persistent Opioid Use After Gynecologic Surgery: A Systematic Review.妇科手术后急性疼痛的处方阿片类药物使用及持续阿片类药物使用:一项系统评价
Obstet Gynecol. 2023 Apr 1;141(4):681-696. doi: 10.1097/AOG.0000000000005104. Epub 2023 Mar 9.
2
Perioperative opioid dispensing and persistent use after benign hysterectomy: a systematic review and meta-analysis.良性子宫切除术后围手术期阿片类药物配给与持续使用:系统评价和荟萃分析。
Am J Obstet Gynecol. 2023 Jul;229(1):23-32.e3. doi: 10.1016/j.ajog.2022.12.015. Epub 2022 Dec 17.
3
Perioperative opioid management for minimally invasive hysterectomy.
微创子宫切除术的围手术期阿片类药物管理
Best Pract Res Clin Obstet Gynaecol. 2022 Dec;85(Pt B):68-80. doi: 10.1016/j.bpobgyn.2022.05.006. Epub 2022 Jun 6.
4
Postoperative Discharge Opioid Consumption, Leftover, and Disposal after Obstetric and Gynecologic Procedures: A Systematic Review.术后阿片类药物出院消耗、剩余和妇产科手术后处置:系统评价。
J Minim Invasive Gynecol. 2022 Jul;29(7):823-831.e7. doi: 10.1016/j.jmig.2022.04.017. Epub 2022 May 2.
5
Predictors of new persistent opioid use after benign hysterectomy in the United States.美国良性子宫切除术后新发持续性阿片类药物使用的预测因素。
Am J Obstet Gynecol. 2022 Jul;227(1):68.e1-68.e24. doi: 10.1016/j.ajog.2022.02.030. Epub 2022 Mar 3.
6
Perioperative opioid prescriptions associated with stress incontinence and pelvic organ prolapse surgery.围手术期阿片类药物处方与压力性尿失禁和盆腔器官脱垂手术相关。
Am J Obstet Gynecol. 2020 Dec;223(6):894.e1-894.e9. doi: 10.1016/j.ajog.2020.07.004. Epub 2020 Jul 9.
7
Outcomes and patient perspectives following implementation of tiered opioid prescription guidelines in gynecologic surgery.妇科手术后实施分层阿片类药物处方指南的结果和患者观点。
Gynecol Oncol. 2020 May;157(2):476-481. doi: 10.1016/j.ygyno.2020.02.025. Epub 2020 Feb 24.
8
The impact of an enhanced recovery after minimally invasive surgery program on opioid use in gynecologic oncology patients undergoing hysterectomy.微创手术后强化康复方案对妇科肿瘤行子宫切除术患者阿片类药物使用的影响。
Gynecol Oncol. 2020 May;157(2):469-475. doi: 10.1016/j.ygyno.2020.01.041. Epub 2020 Feb 12.
9
Implementing robotic surgery for uterine cancer in the United States: Better outcomes without increased costs.美国实施机器人手术治疗子宫癌:更好的疗效,无增加成本。
Gynecol Oncol. 2020 Feb;156(2):451-458. doi: 10.1016/j.ygyno.2019.11.016. Epub 2019 Nov 25.
10
Use and Misuse of Opioids After Gynecologic Surgical Procedures.妇科手术后阿片类药物的使用和滥用。
Obstet Gynecol. 2019 Aug;134(2):250-260. doi: 10.1097/AOG.0000000000003358.